Approval · Notice of Compliance 37859 · 2026
CYSTADANE: Notice of Compliance 37859
Issued July 8, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37859
- Date
- July 8, 2026
- Company
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSTADANE | Not yet assigned | — |
Medicinal ingredients
- BETAINE 1 G per 1.7CC